Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,490.00    20.00 (0.37%)
Bid:
5,490.00
Ask:
5,500.00
Spread: 10.00 (0.182%)
Market Cap: £2.94b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

CMD and upgraded medium term targets

20 Mar 2025 07:00

RNS Number : 3755B
Cranswick PLC
20 March 2025
 

20 March 2025

 

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

 

Capital Markets Day and upgraded medium term targets

 

Cranswick, a leading UK food producer, is today hosting a Capital Markets Day in London for analysts and institutional investors.

 

Presented by a selection of the Group's senior leaders, the event will provide an update on the Group's strategy, its successful compounding track record and how key strategic enablers will drive further growth.

 

Today's event will cover the following:

 

· Securing pig supply, driving competitive advantage and leveraging genetics capability

· Investing in fresh pork processing to add capacity and enhance automation

· Maximising the fresh poultry supply chain opportunity and growing poultry processing capacity

· Differentiated product portfolio and further premiumisation

· Strength and depth of customer relationships, including new long-term agreements

 

We will also outline upgraded medium term targets reflecting strengthening returns from disciplined capital allocation, as follows:

 

· Mid single digit organic revenue growth1

· ~7.5% adjusted operating margin2, increased from >6%

· Mid single digit adjusted EPS growth2 maintained

· Upper teens ROCE3, increased from mid-teens

· 4 maintained

· 90% free cash conversion5 maintained

 

For those unable to attend in person, a copy of the presentation and an audio recording will be made available after the event at www.cranswick.plc.uk.

 

Outlook

Robust demand for our core pork and poultry products has continued through the fourth quarter. The outlook for the current financial year ending 29 March 2025 remains in line with current market expectations6. No further material commentary on current trading and outlook will be provided at today's event.

 

Preliminary results

The Company's preliminary results announcement for the 52 weeks ending 29 March 2025 will be released on Tuesday 20 May 2025.

 

Adam Couch, CEO of Cranswick, commented:

"2025 marks Cranswick's 50th anniversary and today's Capital Markets Day event is a fantastic opportunity to reflect on our successful business model and strategy which have delivered strong, compound returns for our shareholders and compelling future growth opportunities.

 

"We are also announcing today more ambitious medium-term financial targets, reflecting the significant strategic progress we have made since first introducing these measures.

 

"Our relentless focus on the strengths of the business, which include industry leading investment, a clearly defined strategy, broadening product portfolio and unrivalled management team, will continue to support the future successful development of Cranswick over the long term."

 

 

1

2

3

 

4

5

 

6

Excludes the impact of M&A.

Excludes IAS 41 movement on biological assets, acquisition related amortisation and impairment of intangible assets.

Adjusted operating profit divided by the sum of average opening and closing net assets, net debt, pension surplus and deferred tax.

Net debt (including IFRS 16) divided by adjusted EBITDA.

Defined as the sum of net cash from operating activities less interest paid, non-growth capital expenditure, net IAS 41 valuation, lease capital and lease interest divided by adjusted profit for the year.

Market expectations for adjusted profit before tax as at 20 March 2025 range between £190.0m and £195.1m. The range reflects all published Broker analysis.

 

Enquiries:

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Sodali & Co

+44 207 100 6451

Ben Foster / Louisa Henry / Flora Mackenzie

cranswick@sodali.com

 

 

Note to editors:

1. Cranswick is a leading and innovative supplier of premium, fresh and added-value food products. The business employs over 15,000 people and operates from 22 well-invested, highly efficient facilities in the UK. Cranswick was formed in the early 1970s by farmers in East Yorkshire to produce animal feed and has since evolved into a business which produces a range of high quality, predominantly fresh food, including fresh pork, poultry, convenience, gourmet products and pet food. The business develops innovative, great tasting food products to the highest standards of food safety and traceability. The Group supplies the major grocery multiples as well as the growing premium and discounter retail channels. Cranswick also has a strong presence in the 'food-to-go' sector and a substantial export business. Results for the 53 weeks to 30 March 2024 showed revenue of £2,599.3m and profit before tax of £158.4m. For more information go to: www.cranswick.plc.uk

2. At Cranswick, it is second nature for us to protect and nurture our environment while supporting people and communities to thrive. Guided by our sustainability strategy, Second Nature, we have seamlessly integrated our sustainability commitments into the core of our business model, which in turn shapes our decision-making, culture, and actions. For more information on out Second Nature strategy, please visit: www.cranswick.plc.uk/sustainability

3. This announcement contains certain forward-looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAPDNFESSEFA
Date   Source Headline
20th May 202112:03 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSChange of Chairmanship
18th May 20217:00 amRNSPreliminary Results
4th May 20213:56 pmRNSTotal Voting Rights
1st Apr 20213:32 pmRNSBlock listing Interim Review
1st Apr 20213:31 pmRNSBlock listing Interim Review
1st Apr 20213:29 pmRNSTotal Voting Rights
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:47 amRNSDirector/PDMR Shareholding
23rd Mar 20216:03 pmRNSHolding(s) in Company
23rd Mar 20219:07 amRNSDirector/PDMR Shareholding
23rd Mar 20219:06 amRNSDirector/PDMR Shareholding
16th Mar 20211:29 pmRNSDirector/PDMR Shareholding
16th Mar 20218:30 amRNSNon-Executive Director Appointment
2nd Mar 20217:30 amRNSDirector/PDMR Shareholding
15th Feb 20212:59 pmRNSDirector/PDMR Shareholding
4th Feb 20217:00 amRNSThird Quarter Trading Statement
1st Feb 202110:29 amRNSTotal Voting Rights
28th Jan 20213:01 pmRNSAdditional Listing
28th Jan 20217:44 amRNSAdditional Listing
25th Jan 202112:31 pmRNSDirectorship
13th Jan 20218:38 amRNSHolding(s) in Company
4th Jan 20212:19 pmRNSTotal Voting Rights
24th Dec 20207:51 amRNSHolding(s) in Company
24th Dec 20207:49 amRNSDividend Announcement
17th Dec 20207:00 amRNSWithdrawal from Acquisition Process
16th Dec 202011:22 amRNSResponse to Press Speculation
11th Dec 20208:39 amRNSHolding(s) in Company
1st Dec 20208:26 amRNSTotal Voting Rights
24th Nov 20203:45 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSInterim Results
18th Nov 20204:37 pmRNSHolding(s) in Company
3rd Nov 20205:15 pmRNSTotal Voting Rights
27th Oct 20202:55 pmRNSHolding(s) in Company
27th Oct 20202:51 pmRNSHolding(s) in Company
26th Oct 202011:51 amRNSHolding(s) in Company
1st Oct 20201:54 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20201:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20201:49 pmRNSTotal Voting Rights
25th Sep 20202:34 pmRNSHolding(s) in Company
2nd Sep 20202:01 pmRNSAdditional Listing
1st Sep 202011:45 amRNSDirector/PDMR Shareholding
1st Sep 202011:18 amRNSTotal Voting Rights
17th Aug 20202:57 pmRNSPoll Result for 2020 Annual General Meeting
17th Aug 20207:00 amRNSFirst quarter trading statement
11th Aug 20207:00 amRNSAnnual General Meeting update
3rd Aug 20202:30 pmRNSTotal Voting Rights
31st Jul 202012:26 pmRNSDirector/PDMR Shareholding
31st Jul 202012:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.